Polyploid giant cancer cells (PGCCs) have been observed by pathologists for over a century. PGCCs contribute to solid tumor heterogeneity, but their functions are largely undefined. Little attention has been given to these cells, largely because PGCCs have been generally thought to originate from repeated failure of mitosis/cytokinesis and have no capacity for long-term survival or proliferation. Here we report our successful purification and culture of PGCCs from human ovarian cancer cell lines and primary ovarian cancer. These cells are highly resistant to oxygen deprivation and could form through endoreduplication or cell fusion, generating regular-sized cancer cells quickly through budding or bursting similar to simple organisms like fungi. They express normal and cancer stem cell markers, they divide asymmetrically and they cycle slowly. They can differentiate into adipose, cartilage and bone. A single PGCC formed cancer spheroids in vitro and generated tumors in immunodeficient mice. These PGCCderived tumors gained a mesenchymal phenotype with increased expression of cancer stem cell markers CD44 and CD133 and become more resistant to treatment with cisplatin. Taken together, our results reveal that PGCCs represent a resistant form of human cancer using an ancient, evolutionarily conserved mechanism in response to hypoxia stress; they can contribute to the generation of cancer stem-like cells, and also play a fundamental role in regulating tumor heterogeneity, tumor growth and chemoresistance in human cancer.
INTRODUCTION
Almost all human tumors display some heterogeneity.
1,2 Among the many histopathologic features of human solid tumors is the presence of large atypical cancer cells with multiple copies of DNAs, 3 referred to here as polyploid giant cancer cells (PGCCs). PGCCs vary in number and usually become prominent in high pathologic grades and late disease stages, or after chemotherapy. Nuclear features of PGCCs have been used to predict prognosis for ovarian cancer. 4 The giant cells have often been thought to originate from repeated mitosis/cytokinesis failure or as intermediate products of genomic instability. 5, 6 As a result, no reports have been made of their isolation in culture or of their detailed characterization, and the function, mechanisms of formation and the role of PGCCs in the development of human tumors are largely undefined.
Hypoxia is known to play an important role in normal tissue and tumor development 7, 8 and is associated with the formation and maintenance of cancer stem cells; 9 it further promotes the stemlike phenotype and tumorigenesis. 10 Cobalt chloride (CoCl 2 ) has been used as a hypoxia mimic in cell culture and can activate hypoxia-mediated signaling pathways. 11 Here we report the successful purification and stable maintenance of PGCCs from cancer cell lines and human primary ovarian tumors with the use of CoCl 2 . Our studies of stably passaged PGCCs revealed many unexpected biologic features. The division patterns of PGCCs are remarkably similar to those of simple organisms. These results strongly suggest that PGCCs represent a dormant form of cancer cells in a stress-induced cancer cell life cycle that can actively contribute to tumor growth through the generation of cancer stem-like cells.
RESULTS

PGCCs exist in several cancer cell lines
Scattered giant PGCCs were observed in HEY, SKOv3 and MDA-MB-231 cell cultures grown in regular media. Addition of CoCl 2 to the medium selectively killed the regular-sized cancer cells but not the PGCCs. Typical PGCCs from HEY and MDA-MB-231 cells were morphologically similar to neurons. PGCCs from SKOv3 cells were round and lacked branches ( Figure 1A ). The genotypes of the PGCCs arising from CoCl 2 treatment were identical to those of the parental cell lines, as confirmed by short tandem repeat DNA profile analysis (Supplementary Table S1 ). We also treated 10 ovarian cancer cell lines, including two newly established lines from primary ovarian cancer culture, the breast cancer cell line MCF-7, phoenix cells and 293T cells (Supplementary Figure S1A) with CoCl 2 , and all showed enriched or purified PGCCs after CoCl 2 treatment. PGCCs could also be induced by physiological hypoxia when cultured with 0.1% oxygen (Supplementary Figure S1B) . Morphological characteristics common to all PGCCs were their large size and giant nucleus, which were present in all of the examined cell lines. Typically, the PGCCs were 3-10 times larger than the regular cancer cells. We define the PGCC as a cancer cell that is at least three times larger than the parental cancer cells.
Characterization of PGCCs
Flow cytometric analysis indicated the presence of more G 2 /Mphase cells and also more PGCCs after CoCl 2 treatment ( Figure 1B) . The presence of multiple DNA copies in individual PGCCs was confirmed by X-chromosome fluorescence in situ hybridization ( Figure 1C ). PGCCs were not senescent, as shown by negative b-galactosidase (b-Gal) staining ( Figure 1D ). Because CoCl 2 mimics hypoxia by stabilizing the hypoxia-inducible transcription factor 1a (HIF-1a), 12 we examined the expression of HIF-1a and found that HIF-1a expression was markedly elevated in PGCCs relative to levels in regular HEY and SKOv3 cells ( Figure 1E ). Expression of the elongation initiation factor-2a was also downregulated in PGCCs ( Figure 1E ), suggesting that protein translation may be turned off in these cells to keep cell cycling slow. PGCCs undergo asymmetric division and cycle slowly We observed two asymmetric cell division patterns in PGCCs: budding and bursting, individually or in combination. Budding of daughter cells from PGCCs usually occurred from the branches of PGCCs (Figure 2A ; HEY PGCC1) and from the body of PGCCs that contained multiple nuclei and was followed by the burst release of numerous small daughter cells (Figure 2A ; HEY PGCC2 and MDA-MB-231 PGCC). To confirm the division by budding, we used timelapse imaging analysis of a HEY PGCC and revealed budding of small daughter cells from the body of that PGCC ( Supplementary  Figures S2A and S2B) . These results suggest that PGCCs produce daughter cells through budding, similar to simple organisms such as yeasts or other unicellular organisms. 13, 14 Two types of PGCCs were observed after staining: giant nucleated cells or multinucleated giant cells. Cell budding from each of the two types of PGCCs from HEY, SKOv3 and MDA-MB-231 cells is shown in Figure 2B . We counted the numbers of purified HEY PGCCs every 2 days for 15 days; the total number of small cells increased minimally during the first 8 days, after which a large number of small cells started to bud out on the ninth day, followed by an explosive increase in the total number of cells ( Figure 2C ). To further characterize the nature of the division of PGCCs, we labeled PGCCs with PKH26, which is usually lost quickly in rapidly dividing cells. 15 We monitored the daughter cells from the PGCCs in vitro and in vivo as follows. First, PGCCs and daughter cells were stained with PKH26 and observed over a period of 5 days. The PGCCs showed continued fluorescence on day 5, whereas fluorescence was largely absent in the daughter cells ( Figure 2D and Supplementary Figure S3A) . We further used nocodazole (a cell cycle inhibitor) in an effort to inhibit the generation of daughter cells, and the fluorescent PKH26 dye was maintained in PGCCs even after day 10 (Supplementary Figure S3B) . In vivo, we subcutaneously injected 3000 PGCCs labeled with PKH26 into the nude mice and examined frozen tumor sections for fluorescence 28 days after injection of PGCCs. A few PGCCs with red fluorescence were observed in the tumor tissue, but most of the other tumor cells had lost fluorescence ( Figure 2D ), demonstrating that the PGCCs were also slow-cycling in vivo.
PGCCs can generate tumor spheroids When PGCCs were cultured in stem cell medium, many spheroids of HEY, SKOv3 and MDA-MB-231 cells appeared in the flasks ( Figure 3A) . Further, spheroids formed from a single PGCC of HEY, SKOv3 or MDA-MB-231 cells were observed when grown in stem cell medium and Matrigel ( Figure 3A ). To further demonstrate the ability of each single PGCC to form spheroids, we serially diluted HEY PGCCs in Matrigel with 3-5 PGCCs in each well of a 24-well plate. Single PGCCs could form spheroids on the fifth day after seeding in Matrigel (Figures 3Ba and b) . When spheroids from HEY PGCCs embedded in paraffin blocks were subjected to immunohistochemical staining, they were positive for CD44 and CD133 (Figures 3Bc and d) .
To determine the tumorigenicity of PGCCs in vivo, we subcutaneously injected a single spheroid derived from a single HEY PGCC into the three nude mice. Six tumors formed, two at each of the two injection sites in each of the three nude mice. Histological examination showed that the resulting tumor cells had a higher nucleus-to-cytoplasm ratio and were more mesenchymal morphologically (Figure 3Bf ). The spheroids from HEY-and MDA-MB-231-derived PGCCs showed scattered cells that stained positively for OCT3/4, Nanog, SOX-2 and ABCG2 ( Figure 3C ), suggesting that at least part of the cells within these spheroids may have gained stem-like properties. The PGCC spheroid-derived tumors had lower cytokeratin expression and higher vimentin expression than did the control tumor cells ( Figure 3D ). Immunohistochemical staining revealed the presence of CD44 and CD133 in the PGCC spheroid-derived tumors, whereas most of the tumor cells generated from injection of regular HEY cells were negative ( Figure 3D ). The relative expression of cytokeratin, vimentin, CD44 and CD133 between PGCCs, PGCCs with budding and regular cancer cells were further validated by western blotting ( Figure 3E ). CD133 and CD44 were most highly expressed in PGCCs with budding, suggesting that these budded cells have properties of cancer stem-like cells.
Alteration of cell cycle-related protein expression in PGCCs We next examined the expression of a panel of proteins involved in cell cycle regulation in PGCCs from HEY and SKOv3 cells. The expression of p53 protein was elevated in PGCCs and PGCCs with budding. In HEY cells, the expression of cyclin E and cyclin D1 was markedly elevated in purified HEY PGCCs versus regular HEY cells. HEY PGCCs with budding had the highest expression of CDK2 and cyclin B1. In SKOv3 cells, increased expression of CDK2 and cyclin D1 was found in purified SKOv3 PGCCs, but the levels of cyclin B1, cyclin E and CDK4 expression were lower in the PGCCs than in the control SKOv3 cells ( Figure 4A ). These results demonstrate that PGCCs express distinct profiles of proteins involved in cell cycle regulation that differ according to the parental cells.
DNA transport within PGCCs and PGCC formation by cell fusion As PGCCs produce daughter cells via budding from the branches, we examined how DNA is transported within branches of PGCCs. We stained these cells with Hoechst33342 to trace the PGCC branches for the presence or absence of DNA after trypsin digestion. DNA was not found in the branches of HEY PGCCs at 8 h after digestion (Figures 4Ba and b) . However, DNA reappeared in the branches at 4 days after trypsin digestion (Figures 4Bc and d ). These results demonstrate that the branches of PGCCs can serve as vessels for DNA transport. DNA transportation in the branches was also observed in MDA-MB-231 PGCCs and in PGCCs from human ovarian cancer primary culture (Figures 4Bg and h) .
Giant cells or giant cancer cells have been reported to form through cell fusion. [16] [17] [18] [19] To determine whether cell fusion is involved in PGCC formation, we mixed (Table 1 and Figure 5B ). Tumor formation ability was also determined in a different mouse strain-in NOD.CS17-Prkdc SCID mice. By the 25th day after injection, tumors had formed in 3 of 4 mice injected with a single HEY PGCC; in contrast, a tumor formed in only 1 of 4 mice injected with 10 regular HEY cells, but in 4 of 4 mice injected with 100 and 1000 regular HEY cells (Table 1) . In nude mice, tumors formed in 7 of 12 nude mice injected with a single SKOv3 PGCC and in 8 of 12 nude mice injected with a single MDA-MB-231 PGCC. Thus, the rates of tumor formation after injection of single PGCCs were higher than after injection of 10, 100 or 1000 regular cancer cell controls (Table 1) . Immunohistochemical staining of HEY PGCCderived tumors also demonstrated high expression levels of cyclin D1, cyclin E, CDK2 and cyclin B as compared with regular HEY cancer cell-derived tumors ( Figure 5C ).
Differentiation of PGCCs into adipose, cartilage and bone In our examination of whether these PGCCs could differentiate into other stromal cell types, we found that PGCCs cultured with adipogenesis medium showed strong staining with Oil Red O (Figure 6Ab ) and increased the expression of FABP4 (Figure 6Ad ) compared with regular HEY cells (Figures 6Aa and c) . Next, we injected 1 Â 10 4 PGCCs cultured with adipogenesis medium subcutaneously into the nude mice. Histologic examination of the resulting tumors showed large amounts of adipose tissue intermixed with the tumor cells (Figure 6Ae ). Adipose differentiation was confirmed by FABP4 immunohistochemical staining (Figure 6Af) , and the human origin of these cells was confirmed by human-specific vimentin (Figures 6Ag and h) . We further cultured PGCCs and regular HEY cells in the chondrogenesis medium. Although regular Hey cells showed no obvious morphologic changes (Figure 6Ba ), the PGCCs formed chondrogenic pellets (Figure 6Bb ) that stained strongly with Alcian Blue and periodic acid-Schiff (PAS) (Figures 6Bc and d) . We next injected the chondrogenic pellets subcutaneously near the ribs in five nude mice and percutaneously into the abdominal cavity of another five nude mice. All five of the animals injected subcutaneously demonstrated translucent tumor nodules similar to the cartilage near the site of injection (Figure 6Ca) . Four of the five abdominal cavity injections resulted in solid tumor formation (Table 1) . Histologic examination revealed osteoid structures within the tumor tissue (Figure 6Cb ). Osteoid differentiation was confirmed by Safranin O/Fast Green staining (Figure 6Cc ). The osteoid tissue was also positive for anti-eGFP (Figure 6Cd ), confirming the human origin of the bone tissue. Interestingly, one of the five abdominal cavity injection tumor cells formed small, loose tumor bodies 1-2 mm in diameter (Figure 6Ce ). Hematoxylin and eosin staining of these loose bodies showed cartilaginous tissue in the center of the small bodies (Figures 6Cf and g ). That tissue was positive for osteopontin (Figure 6Ch ), demonstrating that PGCCs can differentiate into cartilage and bone.
MDA-MB-231 PGCCs also formed chondrogenic pellets when cultured with the chondrogenesis medium (Figure 6Da ), which also stained strongly with Alcian Blue and PAS (Figures 6Db and c) . When the chondrogenic pellets were injected into the abdominal body cavities of the nude mice, small, loose tumor bodies formed in 5/5 mice ( Figure 6Dd) ; chondrogenic pellets injected subcutaneously into the nude mice led to the development of tumors with calcification, confirmed with computed tomography and hematoxylin and eosin staining (Figures 6De and f) in 5/5 mice (Table 1) . These loose tumor bodies had components of cartilage and bone, as verified by immunohistochemical staining for osteopontin ( Figure 6Dg) ; they also had components of adipose tissue, the human origin of which was confirmed by immunohistochemical staining for human-specific vimentin (Figure 6Dh ).
Relationship between numbers of PGCCs and resistance to CoCl2 or cisplatin Primary culture of tumors derived from a single injection of HEY PGCCs led to a marked increase in the total number of PGCCs relative to HEY cells, and these PGCCs survived treatment with 300 mM CoCl 2 (Supplementary Figure S4A) . Next, we treated regular HEY cells and HEY PGCCs enriched by CoCl 2 with 10 mg/ml cisplatin for 48 h. Almost all of the control HEY cells died, but the CoCl 2 -enriched PGCCs survived (Supplementary Figure S4B) . To determine whether PGCCs would survive chemotherapy in vivo, we examined specimens from five women with ovarian cancer obtained before and after chemotherapy. The numbers and size of 
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PGCCs were markedly increased in the post-chemotherapy samples relative to the pre-chemotherapy samples for all five cases of human ovarian cancer examined (Supplementary Figure S4C) .
PGCCs in human ovarian tumors
To validate our findings in cancer in humans, we looked for PGCCs in specimens of benign and malignant ovarian tumors. PGCCs were observed in serous cystadenoma, high-grade serous ovarian carcinoma and metastatic high-grade serous ovarian carcinoma ( Figure 7A ). The number of PGCCs increased sharply with increased stage and tumor grade. PGCCs in a culture of highgrade serous ovarian carcinoma are shown in Figure 7Ba small arrows) with distinct nuclei indicated by Hoechst33342 staining (Figure 7Be ). Culturing these PGCCs in stem cell medium led to the formation of tumor spheroids (Figure 7Bf) , with numerous small cancer cells budding from them (arrows). Observations of these PGCCs over a 9-day period revealed a burst release of numerous small cancer cells ( Figure 7C ). 20 In eukaryotes, mitosis is the recognized manner of cell division that ensures the accurate distribution of duplicated genetic materials to progeny cells. 21, 22 In prokaryotes and unicellular eukaryotes, cells divide by amitotic processes, including branching followed by binary fission and budding. Although mitosis prevails in complex eukaryotes, well-documented variations of the mitotic cell cycle can occur to meet growth and developmental needs under stresses. 13 Among these variations is the endocycle (or endoreduplication), a variation of the normal mitotic cell cycle involving multiple rounds of DNA replication without an intervening mitosis step. This process is an evolutionarily conserved means of generating multinucleated cells and is commonly used for certain forms of growth in plants, insects and trophoblasts. 13, 23 Stress, aging and an abortive cell cycle can also contribute to the generation of PGCCs. 24 Cell fusion is another important mechanism that contributes to the formation of PGCCs and is known to play an important role in cancer progression. 18 Certain antimitotic chemotherapy drugs increase the formation of giant cancer cells, which are often considered to be at the stage of mitotic catastrophe and subsequent apoptosis. However, very little attention was paid as to whether PGCCs can survive these treatments and become resistant cancer cells or cancer stem cells. 25 PGCCs can generate daughter cells through budding and bursting; these growth patterns are very different from the traditional mitotic growth of eukaryotic diploid cells. Giant cells have been reported to revert to regular-sized cancer cells through a process of reduction division, which others have called neosis or depolyploidization. [26] [27] [28] Neosis or reductive cell division of giant cancer cells via meiosis-like depolyploidization 28 has been proposed to explain this new life cycle of these cells. 29, 30 Despite these previous reports, 27, 31 PGCCs have not attracted much attention in the cancer research community and their roles in tumorigenesis have been largely untested. Our findings presented here demonstrated that PGCCs are as an integral part of the cancer cell life cycle that has been overlooked for many years.
DISCUSSION
The advantages of PGCCs are several. First, giant cells are sufficiently flexible to meet tumor developmental needs. Second, PGCCs contain multiple copies of genes, which give them the ability to generate the functions of different cell types via epigenetic changes and DNA recombination. Third, PGCCs may have different metabolic processes from regular-sized cancer cells 13 that would allow PGCCs to be more adaptable to stress and hypoxic microenvironments. Finally, the ability of PGCCs to release progeny cells by efficient processes such as budding or bursting may resemble the mechanisms used to shed progeny viruses from an infected host cell. 32 Thus, PGCCs have a distinct advantage over diploid cancer cells in dealing with stresses and reproduction; 33 in this regard, PGCCs also share some resemblance to the spores of low organisms. 34, 35 Taken together, our findings suggest that PGCCs have a novel stress-induced cancer cell life cycle evoked through an ancient, evolutionarily conserved mechanism that cancer cells use in response to stress and to meet the demand for the fast reproduction. Thus, PGCCs are integral part of cancer cell life cycle and play an important role in generating tumor heterogeneity, tumor growth and chemoresistance.
MATERIALS AND METHODS
Cell lines and culture conditions
The human ovarian cancer cell lines HEY and SKOv3 have been described previously by our laboratory. 36 The breast cancer cell line MDA-MB-231 were purchased from the American Type Culture Collection (Manassas, VA, USA). HEY and SKOv3 cells were maintained in Eagle's minimum essential medium, and MDA-MB-231 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, penicillin (100 U/ml) and streptomycin (100 mg/ml).
Induction and maintenance of PGCCs
All cell lines were cultured in complete medium until the cells reached 90% confluence. Different concentrations of CoCl 2 were added to the flasks and the cells were cultured for different intervals. The CoCl 2 concentrations and culture times varied depending on the overall condition of the different cell lines (Supplementary Table S2 ). After CoCl 2 treatment, almost all regular-sized cells died, and several PGCCs survived and recovered for purification.
Flow cytometry
Cell cycle status was detected by flow cytometry as described previously 37 and was analyzed by the CellQuest software (BD Biosciences, San Jose, CA, USA).
X-chromosome fluorescence in situ hybridization A CEP X SpectrumOrange Direct Labeled Fluorescent DNA Probe Kit and the probe specific for the X chromosome were purchased from Vysis (Abbott Molecular, Des Plains, IL, USA). Fluorescence in situ hybridization was performed according to the manufacturer's instructions.
Acidic b-Gal staining b-Gal staining was carried out as described previously. 38 
PKH26 staining and animal injection
The PGCCs were stained with PKH26 (Sigma-Aldrich, St Louis, MO, USA) according to the manufacturer's instructions. Each stained PGCC was monitored for its division pattern in a tissue culture dish every 12 h. For the in vivo experiments, 3000 PGCCs that had been stained with PKH26 were injected subcutaneously into the nude mice. The mice were killed 28 days after injection, and frozen sections of tumor were examined for fluorescence from the PKH26-stained cells.
Formation of spheroids
Stem cell medium (Gibco/Invitrogen, Grand Island, NY, USA) was used to grow spheroids as follows. P GCCs were cultured in stem cell medium for 7-10 days; during that time the PGCCs grew as spheroids either floating in the medium or attached to the wall of the flask. For experiments with spheroids in Matrigel (no. 356237; BD Biosciences, San Jose, CA, USA), PGCCs were mixed with Matrigel and with complete Eagle's minimum essential medium at a 1:1 ratio in a total volume of 200 ml on 24-well plates.
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